J Nephropathol. 2020;9(3): e25. doi: 10.34172/jnp.2020.25

Original Article

Comparison of the effects of pramipexole and gabapentin on the treatment of restless leg syndrome in end-stage chronic renal failure patients undergoing hemodialysis

Sepideh Hajian 1 * ORCID, Mohammad Reza Rajabpoor Nikfam 2, Zahra Esmayeilzad 2 ORCID

Cited by CrossRef: 0

1- Chen J, Lee T, Tu Y, Kuo G, Yang H, Yen C, Fan P, Chang C. Pharmacological and non-pharmacological treatments for restless legs syndrome in end-stage kidney disease: a systematic review and component network meta-analysis. 2021; [Crossref]
2- Tang M, Ge J, Sun K, Cui B, Guan Y, Wang J. A network meta‚Äźanalysis of the effectiveness and safety of drugs for restless legs syndrome in dialysis patients. Seminars in Dialysis. 2022;35(4):293 [Crossref]